title: [Prevention of hepatitis C at Center for Haemodialisys of Clinical Centre of University of Sarajevo].
abstract: OBJECTIVE
  The patients with the chronical programm for haemodialisys have the higher risk from getting ill virus hepatitis C in the realtion to the rest population.
  
  
  OBJECTIVE
  Was the evaluation of the prevalence and incidence of hepatitis C at the Center for Haemodialisys CCU Sarajevo and the effect of the prevalentive measures on the incidence of the serum conversion of hepatitis C, in the period from 2002 till 2004 year.
  
  
  METHODS
  By the examening is comprehended 155 patients aged 54,58 +/- 14,797 years, with the aproximative length of the haemodialisys 58,9 +/- 53,9 months. Patients at the chronic programm of the bicarbonite haemodialisys taree times per week, and antibodies on the hepatitis C were determined III generation. Also was determined PCR.
  
  
  RESULTS
  During the periiod of examination the dialized population was increased also 2002 year the prevalence of hepatitis C was 23,87% (37/155), in 2003 year 29,29% (46/157) and 2004 year the pregalence amounted 26,28% (46/175). Incidence of hepatitis C was significantly decreased in the course of the period of followup and in 2002 year was 16,21%, in 2003 year 13,04%, that in 2004 year would amount 4,34%, that is only in two patients occurred the serum conversion on hepatitis C.
  
  
  CONCLUSIONS
  By applying of the corresponding protocoles and their strict realization (desinfection of the hands, wearing of gloves, apparatus desinfection) and separation of the dialyzed monitors for anti HCV positive and anti HCV negative patients dicreased significantly the hepatitis C incidence in our dialyzed population. The strict application of the preventive measures can completely prevent the speading occurrence of hepatitis C on haemodialisys.
authors.affiliation: Centar za Hemodijalizu, Klinicki Centar Univerziteta u Sarajevu.
authors.forename: Sanja
authors.initials: S
authors.lastname: Miseljić
authors.forename: Halima
authors.initials: H
authors.lastname: Resić
authors.forename: Emir
authors.initials: E
authors.lastname: Avdić
authors.forename: Ibrahim
authors.initials: I
authors.lastname: Osmić
authors.forename: Dzana
authors.initials: D
authors.lastname: Helać-Cvijetić
authors.forename: Vahidin
authors.initials: V
authors.lastname: Sahović
authors.forename: Melka
authors.initials: M
authors.lastname: Avdagić
authors.forename: Hasan
authors.initials: H
authors.lastname: Barhawi
authors.forename: Aida
authors.initials: A
authors.lastname: Corić
authors.forename: Nenad
authors.initials: N
authors.lastname: Miseljić
authors.forename: Selma
authors.initials: S
authors.lastname: Ajanović
mesh_terms: D003428:Cross Infection / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D005260:Female; D006436:Hemodialysis Units, Hospital; D006526:Hepatitis C / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D018937:Hepatitis C Antibodies / Q000097:blood; D006801:Humans; D008297:Male; D008875:Middle Aged; D015995:Prevalence
chemical_list: D018937:Hepatitis C Antibodies